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minal tail of the HIV-1 gp41 envelope protein inhibited viral-initiated T-cell death and T-cell syncytium formation, at which time
in the HIV life cycle the gp41 protein is embedded in the T-cell membrane. In striking contrast, the mutants did not affect virion
infectivity, during which time the gp41 protein is embedded in the HIV envelope membrane. To examine the role of LLP2/
membrane interactions, we applied synchrotron x-radiation to determine structure of hydrated membranes. We focused on
WT LLP2 peptide (þ3 charge) and MX2 mutant (1 charge) with membrane mimics for the T-cell and the HIV-1 membranes.
To investigate the influence of electrostatics, cholesterol content, and peptide palmitoylation, we also studied three other LLP2
variants and HIV-1 mimics without negatively charged lipids or cholesterol as well as extracted HIV-1 lipids. All LLP2 peptides
bound strongly to T-cell membrane mimics, as indicated by changes in membrane structure and bending. In contrast, none of
the weakly bound LLP2 variants changed the HIV-1 membrane mimic structure or properties. This correlates well with, and
provides a biophysical basis for, previously published results that reported lack of a mutant effect in HIV virion infectivity
in contrast to an inhibitory effect in T-cell syncytium formation. It shows that interaction of LLP2 with the T-cell membrane
modulates biological function.INTRODUCTIONThe HIV-1 envelope glycoprotein (Env) is synthesized as a
160 kDa precursor, gp160, and then proteolytically cleaved
into gp120 and gp41, which remain noncovalently associ-
ated in a trimer arrangement. HIV infection begins when
gp120 contacts the CD4 receptor on the T-cell host, which
is followed by contact with a second chemokine receptor,
and then fusion of the HIV virion and T-cell membranes,
catalyzed by the gp41 fusion protein. The gp41 fusion pro-
tein contains a long (150 AA) cytoplasmic C-terminal tail
(CTT) that is a common feature of lentiviruses but is sig-
nificantly longer than the CTT of other retroviruses. Three
conserved amphipathic, primarily a-helical segments in the
CTT referred to as lentiviral lytic peptides (LLP1, LLP2,
and LLP3) have been shown to bind and perturb mem-
branes (1–5). LLP2 is highly cationic with a preferential
incorporation of arginine residues and it possesses a large
hydrophobic moment (6). To understand the function of
the CTT, deletions of the entire CTT have been carried
out with different results depending upon cell type.
For so-called permissive cell types (HeLa, COS, 293T,
MT-4, and M8166), deletion has little effect on Env incor-
poration into virions (7,8). However, the majority of
T-cell lines (including CED(12D-7), Jurkat, MT-2, H9,
and SupT1) are nonpermissive in that CTT deletion
results in a 10-fold reduction in Env incorporation and a
complete blockage of viral replication (9). Murakami andSubmitted February 8, 2013, and accepted for publication June 24, 2013.
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0006-3495/13/08/0657/10 $2.00Freed found the block to be at the early stage of Env
incorporation (7).
Less drastic changes in the CTT have been carried out
using rational site-directed mutations. Kalia et al. (10), for
instance, produced a mutant MX2 of LLP2 where two high-
ly conserved arginine residues (R3 and R21) were replaced
with negatively charged glutamic acid, thus decreasing the
net charge from þ3 to 1. In virions derived from 293T
cells, MX2 mutation showed no loss of Env expression or
infectivity (10). These events occur when the gp41 protein
is embedded in the HIV envelope membrane. In contrast,
when the gp41 protein is in the T-cell membrane, both
viral-initiated cell death and syncytium formation (cell-
cell fusion) were greatly decreased in H9 cells by the
MX2 mutant (10); this was not a case of permissive versus
nonpermissive cell lines, because this inhibition was also
found in permissive 293T cells using a luciferase expression
fusion assay (10). In addition to these functional variations,
it was demonstrated that the MX2 Env expressed at the
T-cell surface displayed significant differences in reactivity
with monoclonal antibodies compared to wild-type (WT)
Env proteins (11). Changes in antigenicity of the MX2
mutant Env correlated with neutralization resistance of the
mutant virus, which defined the LLP2 domain as a critical
determinant of Env structure and antigenicity (11). How-
ever, a mechanism for the alteration of cell-cell but not
virus-cell functionality by the MX2 mutant was not evident
from the mutational studies. Indeed, a priori it would have
seemed that the CTT should not affect Env activity because
it is on the opposite side of the membrane.http://dx.doi.org/10.1016/j.bpj.2013.06.042
TABLE 1 Lipid composition of membrane mimics
Lipid
Mole percentage
HIV HIV-chol HIV-neg T-cell
C 16 Ceramide 0.8 1.5 1.0 1.1
Soy Phosphoinositol (PI) 1.3 2.3 0 6.3
Brain PI(4)P 1.3 2.3 0 0.9
Brain PI(4,5)P2 1.3 2.3 0 1.1
12:0 diHydroSphingomyelin (diHSM) 1.7 3.1 1.8 2.7
PO-Phosphoethanolamine (POPE) 4.2 7.6 4.7 6.3
PO-Phosphoserine (POPS) 7.5 13.7 0 9.1
Plasmalogen PE 7.5 13.7 8.5 10.9
Egg Sphingomyeline (Egg SM) 14.2 26.0 16.0 16.3
PO-PhosphoCholine (POPC) 15.1 27.5 17.0 15.4
Cholesterol (Chol) 45.2 0 51.0 29.9
Membrane mimics are HIV, HIV-chol (HIV without cholesterol), HIV-neg
(HIV without negatively charged lipids), and T-cell. PO stands for palmi-
toyloleoyl.
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in lipid bilayers to learn how changes in structure and prop-
erties correlate with biological function. We used our pio-
neering method of x-ray diffuse scattering (12–15) from
oriented, fully hydrated peptide/lipid mixtures that pro-
vides both structural and bending flexibility data. As model
HIV-1 and T-cell membranes, we used membrane mimics
composed of 10 lipids and cholesterol based on previous
determinations (16,17), as well as total lipids extracted
from HIV membranes. Two additional HIV membrane
mimics lacking negatively charged lipids (HIV-neg) or
cholesterol (HIV-chol) were also investigated to probe the
importance of negatively charged lipids and cholesterol in
the HIV virion membrane. The primary peptides were WT
and MX2 (WT mutant). We also studied CracWT (WT
with Crac motif), CracWTpal (CracWT with palmitoylated
cysteine), and CracMX2pal (MX2 mutant with Crac and
palmitoylated cysteine). These peptides were specifically
designed to investigate the role of the charge change
from þ3 in the WT to 1 in the MX2 mutant (10), as
well as the effect of a Crac, or cholesterol-binding motif
(18) immediately preceding the LLP2 sequence. Crac motifs
were first discovered in the benzodiazepine receptor (19)
and have a sequence that binds cholesterol (18,20). The pep-
tide variants also tested the role of the palmitoylated
cysteine, which precedes the Crac motif (21,22). Our data
reveal that all peptide variants interact strongly with the
T-cell membrane mimic, as observed by changes in structure
and bending modulus, whereas the peptides only interacted
weakly with the HIV membrane mimic or with the HIV
extracted lipid membrane. Our work provides a structural
basis for the effects seen in mutation studies (10), namely
that LLP2 is a modulator of biological activity in T-cell
membranes and not in HIVenvelope membranes. It suggests
that the T-cell membrane mediates inside-outside signaling
by LLP2 peptides to the ectodomain of the Env protein.MATERIALS AND METHODS
Samples
Purified lipids were purchased from Avanti Polar Lipids (Alabaster, AL)
and used without further purification. Membrane mimic mixtures were pre-
pared by first dissolving lyophilized lipids in chloroform and then mixing
these stock solutions in proportions following (16,17); (17) used H9 cells
for the HIV and T-cell lipidome analysis with conditions that preserved
the phosphoinositides, but because the cholesterol content was not clearly
stated, we also used (16), which used 293T cells. Table 1 shows our lipid
compositions, where PO indicates palmitoyloleoyl. Chemical structures
of lipids are shown in Fig. S1 in the Supporting Material.
HIV-1 virions were procured from the Biological Products Core Labora-
tory, AIDS and Cancer Virus Program, Frederick, MD, where the virus was
attenuated by 1 mM Aldrithiol-2. HIV-1 NL4-3 was produced on host cell
line SUPT1-CCR5 CL.30, Lot P4166. 113  0.25 ml aliquots (total
capsid ¼ 5.7 mg and total protein ¼ 52.3 mg) were sent to our BSL-2þ
facility at the University of Pittsburgh, where we carried out the Bligh/
Dyer (23) lipid extraction. The recovered bottom lipid phase was washed
with authentic upper phase according to the procedure. 33 mg of pureBiophysical Journal 105(3) 657–666HIV lipids were collected from this preparation and divided into 4 mg
aliquots for x-ray sample preparation. Organic solvents were removed by
vacuum drying at room temperature.
Peptides were purchased from the Peptide Synthesis Facility (University
of Pittsburgh, Pittsburgh, PA). Mass spectroscopy revealed >95% purity.
Lentivirus lytic peptide-2 (LLP2 peptides corresponding to residues
#768–788 in the gp160 protein in HXB2) variants were: WT H2N-
YHRLRDLLLIVTRIVELLGRR-COOH, MX2 mutant H2N-YHELRDLL
LIVTRIVELLGRE-COOH (10), (#764–788) CracWTpal H2N-C(pal)-
LFLYHRLRDLLLIVTRIVELLGRR-COOH (24), CracWT H2N-GLFLY
HRLRDLLLIVTRIVELLGRRCOOH, and CracMX2pal H2N-C(pal)-
LFLYHELRDLLLIVTRIVELLGRECOOH. The peptide structures are
shown lined up in Fig. S1. A low synthetic yield of CracMX2pal prevented
using it in all experiments. Peptides and lipids were dissolved in HPLC chlo-
roform and mixed together in molar ratios 20:1 or 40:1 (lipid/peptide). 4 mg
lipid/peptide mixture in HPLC chloroform/trifluoroethanol (TFE) (1:1 v:v)
was plated onto siliconwafers (15 30 1mm)via the rock and rollmethod
(25) to produce ~1800 well-aligned bilayers, and solvents were removed by
evaporation. Before x-ray exposure, samples were prehydrated through the
vapor in polypropylene hydration chambers at 37C for 1–3 h directly before
hydrating in the thick-walled x-ray hydration chamber (13) for 0.5–1 h.
Preequilibration allows sufficient time for equilibrium binding of peptides
with membrane mimics and also reduces mosaic spread.Volume determination
Volumes of lipid mixtures with and without peptides in fully hydrated
multilamellar vesicles were determined at 37 5 0.01C using an Anton-
Paar USA DMA5000M (Ashland, VA) vibrating tube densimeter (26).X-ray scattering and liquid crystal analysis.
Low-angle x-ray scattering (LAXS)
LAXS data from oriented fluid phase lipid mixtures at 37C were obtained
at the Cornell High Energy Synchrotron Source (CHESS) with the scat-
tering geometry shown in Fig. S2 using previously described methods
(12,15). The analysis of diffuse LAXS from oriented stacks of fluctuating
fluid bilayers has been previously described (13). Typical beam width
was 0.25 mm and beam height was 1–1.2 mm. Typical wavelength was
1.1775 A˚ with a total beam intensity of ~1–5  1011 photons/s/mm2.
Typical sample-to-charge-coupled device distance was 376 mm LAXS
and 159 mm wide-angle x-ray scattering (WAXS), calibrated using a silver
behenate standard with D-spacing 58.4 A˚. Temperature was controlled at
37C with a Julabo F25 (Allentown, PA).
 q
z 
(Å
-1
)
0.8
0.6
0.4
0.2
200
400
600
800
1000
1200
1400
1600
0.8
0.6
0.4
0.2
0.8
0.6
0.4
0.2
5
4
3
1
5
4
3
1
2
a  T-cell membrane mimic          b   HIV membrane mimic
h=3
  h=2
Membrane Structure Correlates to LLP2 Function 659Structural analysis
The x-ray jF(qz)j datawere fit to the Fourier transform of a model of the elec-
tron density profilewith components using a scattering density profile (SDP)
procedure (27). TheSDPprocedureguarantees an important relationbetween
the molecular area A and the zeroth-order x-ray form factor F(0) (28):
AFð0Þ ¼ 2ðn rw VÞ;
where V is themeasured volume of the lipid/peptide mixture, n¼ nLþ npepf/
(1-f) is the total, n is the lipid and n is the peptide number of electrons,0 0
–0.2 0 0.2
0
–0.2 0 0.2
0beam
FIGURE 1 Contour plots of LAXS intensity (white is most intense) at
37C where z is the direction of the membrane normal and r is the in-plane
direction. (a) T-cell lipid membrane, (b) HIV lipid membrane. Diffuse scat-
tering lobes (1–5) are identified with large, white numbers. The dark rect-
angle in the lower left corner is due to molybdenum sheets that attenuate the
beam and the h¼ 1–3 diffraction peaks. The unattenuated arcs visible in (b)
emanating from the h ¼ 2 and h ¼ 3 peaks are due to imperfect alignment.L pep
f is the mole fraction of peptide/peptideþ lipid and rW¼ 0.3323e/A˚3 is the
electron density of water at 37C. Informed by our volume measurements,
we constrained the ratio of peptide volume/lipid volume. We also con-
strained the Gaussian sigma widths of the lipid headgroup peaks to 2–
5 A˚, the methyl trough Gaussian sigma to 3–5 A˚ (corresponding to full
width at half-maximum of 7–12 A˚), and the width of the hydrocarbon inter-
face to 2.4 A˚. The peptide width was initially not constrained. The differ-
ence in distance DH1 between the maximum in the electron density
profile and the Gibbs dividing surface for the hydrocarbon region, was
loosely constrained to 4.95 A˚, and the difference in distance DH2 between
the phosphatidylcholine (PC) and carbonyl-glycerol (CG) Gaussians was
constrained to 3.7 A˚. Otherwise, the locations of the components remained
free to provide estimates for the head-head distance and the position of the
peptide in the membrane mimic as previously described (29). The smallest
c2 in the SDP model fit determined the peptide position. Estimated uncer-
tainties in these positions are addressed in Fig. S3.WAXS
The analysis of WAXS data has been previously described (14,30). Briefly,
the orientational order parameter, Sxray, is similar to an NMR order param-
eter and is obtained as described in Fig. S4.Circular dichroism spectroscopy
Samples for CD were prepared by spreading 0.3 mg peptide/lipid mixture in
chloroform/TFE (1:1) onto one inside face of a quartz cuvette to make a
thin film and solvents were removed under vacuum. 100 ml milli-Q water
was introduced and hydration occurred through the vapor in sealed cuvettes
at room temperature for 24 h. Our samples were purposely misoriented dur-
ing spreading onto the cuvette side to minimize orientation effects on CD
spectra (31,32), and two cuvette orientations, vertical and inverted, were
used to sample different parts of the hydrated film. 8–10 scans were
collected with a Jasco 715 on each sample from 260 to 180 nm at
100 nm/minute and averaged. CD data in mean residue ellipiticity were
analyzed using the CDSSTR function in DichroWEB (33) with protein
basis set #4 (34). Uncertainties were estimated by averaging multiple
CDSSTR fits to the data and taking the average and standard deviation.
We also attempted to use the more conventional method of incorporating
LLP2 peptides into small unilamellar vesicles, but this was not successful
with the LLP2 peptide variants. We therefore used another peptide,
a-synuclein (aS) with both the small unilamellar vesicle method and our
thin film method and determined that both methods agreed to within 15%
for the helical content. We also measured the CD of peptides suspended
in 3 ml water (0.008 mg/ml) with no lipid.RESULTS
LAXS
Oriented stacks of ~1800 membrane mimics were hydrated
through the vapor and synchrotron LAXS was obtained as
shown in Fig. 1, a and b, for the T-cell and HIV membranemimics, respectively. Comparison shows that the diffuse
patterns are quite different; most notably, the HIV mem-
brane mimic is missing the second diffuse scattering lobe
compared to the T-cell membrane mimic. This requires
that these membrane mimics have different quantitative
structures (see Fig. S5).
Structurally, raw diffuse scattering, as in Fig. 1, is quan-
tified by the bilayer form factor F(qz), which is the Fourier
transform of the electron density profile along the bilayer
normal, perpendicular to the membrane mimic surface.
Fig. 2 shows F(qz) obtained for the T-cell and HIV mem-
brane mimics with and without the LLP2 variants; the raw
data from which these form factors are derived are shown
in Fig. S6. Fig. 2 a clearly shows that the T-cell mimic
form factors are affected by the addition of these peptides.
A relative decrease in intensity occurs in the second lobe
(near qz ¼ 0.3 A˚1) and a relative increase occurs in the
4th and 5th lobes (near qz ¼ 0.6 and 0.7 A˚1). These
changes in form factors in the T-cell membrane mimic sam-
ples prove that the peptides are binding to the T-cell mem-
brane mimic and affecting its structure. Form factor
results were similar for the 20:1 samples.
Table 2 summarizes the net charges and lamellar repeat
D-spacings for all the samples. Our experimental setup
allows us to change the hydration level, which then changes
D. For the well-hydrated samples reported here these
changes in D do not affect the F(qz) in Fig. 2. However,
the D values are informative regarding electrostatic charge.
Stacks of bilayers with sufficient net charge swell to very
large values of D; this is often called membrane unbinding
(35), not to be confused with unbinding of peptides from
membranes. As an infinite D-spacing would disorient the
sample, an osmotic pressure was imposed to limit the actual
D-spacing of samples that would unbind. AU is written next
to the osmotically imposed actual D-spacing in Table 2 for
those samples that were in the process of unbinding.Biophysical Journal 105(3) 657–666
ab
FIGURE 2 Form factors of T-cell and HIV lipid membranes with and
without LLP2 peptides listed in the legends. T-cell lipid membrane samples
(a) and HIV lipid membrane samples (b) at 40:1 lipid/peptide mole ratio.
Data were normalized in the third lobe (qz ~ 0.43 A˚
1).
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and the HIV membrane mimic has a net charge of 0.15e/
lipid; both membranes unbind. Adding the negatively
charged MX2 mutants increases the negative charges so
those membrane mimics continue to unbind. Adding WT
LLP2 with three positive charges to T-cell membrane
mimics changes the net charge/lipid to 0.125 for 40:1
(unbound) and 0.05 for 20:1 (bound); for HIV samplesTABLE 2 Net charge and lamellar D-spacings
Sample Net charge (e) D-spacing (A˚)
Lipid/peptide mole ratio 20:1 40:1 20:1 40:1
T-cell membrane mimic 0.20 92, U
/WT 0.05 0.125 69 75, U
/MX2 0.25 0.23 86, U 122, U
/CracWTpal 0.05 0.125 68 100, U
/CracWT 0.05 0.125 113, U 143, U
HIV membrane mimic 0.15 119, U
/WT 0 0.075 64 66
/MX2 0.20 0.175 73, U 75, U
/CracWTpal 0 0.075 66 69
/CracWT 0 0.075 65 67
/CracMX2pal 0.20 0.175 69, U 76, U
Samples are T-cell mimics with WT (wild-type), MX2 (WT mutant),
CracWTpal (WT with a cholesterol-binding Crac motif and palmitoylated
cysteine) and CracWT (WT with a Crac motif), and HIV mimic with
WT, MX2, CracWTpal, CracWT, and CracMX2pal (MX2 with a Crac
motif and palmitoylated cysteine). U indicates unbinding of the D-spacing.
Biophysical Journal 105(3) 657–666the net charge/lipid is 0.075 for 40:1 and 0 for 20:1
(both bound). Results for the other WT modifications,
except CracWT(20:1), suggest that the charge threshold
for unbinding occurs for net charge between 0.075
and 0.125 e/lipid.
In contrast to the T-cell, the HIV form factors in Fig. 2 b
exhibit negligible differences for any of the LLP2 analogs
compared to the HIV membrane mimic. Similar to the
HIV mimic samples, the HIV extracted lipid samples are
also missing the second diffuse lobe, and this pattern is
not affected by the peptides as shown by the example in
Fig. S6. This surprising result at first suggested that the pep-
tides had not been incorporated into our samples. However,
that would have resulted in membrane unbinding for all the
HIV samples, which is contrary to the membrane binding
(finite D spacing) that occurs when the WT peptides were
added (see Table 2). Furthermore, it appears that the
peptides, at least those positively charged, remain weakly
bound to the bilayer to reduce its net negative charge and
bring about the finite D spacing. Note that although the
peptide would change the electron density of the water
space, our subsequent analysis indicates that such changes
are consistent with the negligible differences in jF(qz)j in
Fig. 2 b.Electron density profiles
To estimate where the peptides reside within the T-cell
membrane mimic and to verify our observation that the pep-
tides do not enter the HIV membrane mimic, the SDP model
fitting program was used (27). The SDP program fits the
Fourier transform of a real space electron density r(z) model
(27) to the F(qz) data. Fig. 3 a shows an example of the
goodness of the fit to the x-ray form factor data. Fig. 3 b
shows the component groups in the T-cell samples. As
shown, the WT peptide resides in the T-cell headgroup re-
gion, whereas MX2 localizes further into the hydrocarbon
interior. At 40:1 (lipid/peptide mole ratio) both peptides
thin the T-cell membrane mimic, with MX2 causing the
greatest (3 A˚) thinning. Electron density profiles for the
20:1 T-cell samples showed similar thinning and peptide
locations. For the HIV membrane mimics, the peptides
only weakly associated with this mimic and the lipid struc-
tures were unchanged, consistent with unchanged form fac-
tors in Fig. 2 b; LLP2 has an electron density close to water,
so there is insufficient contrast to localize its position or
width. The electron density profiles for the 20:1 and 40:1
HIV samples were similarly unchanged.Bending modulus KC
Table 3 shows the values of the bending modulus, KC, for
three different membrane mimics: T-cell, HIV, and HIV-
neg, and for the HIV extracted lipid membrane. The energy
required to bend a membrane a fixed amount is proportional
ab
FIGURE 3 (a) Model fit to F(qz) obtained from x-ray data and F(0) ob-
tained from volumetric data for T-cell/WT. Modeled total and component
electron density profiles for T-cell samples (b) for 40:1 lipid/peptide. The
component groups are water, PC* (phosphocholine*), Gly-Carb* (glycerol
plus carbonyls*), HC (lipid hydrocarbon chains plus cholesterol), and LLP2
peptides (shaded). *Indicates a weighted average group (see Materials and
Methods). Vertical dotted line facilitates comparison of membrane thickness.
Membrane Structure Correlates to LLP2 Function 661to KC (36). Estimated errors in KC (50.5) were obtained
from data taken at different lateral positions ( Fig. S2) on
the same sample.
The T-cell membrane mimic had a KC value near 7 
1020 J (Table 3), which is typical of commonly studiedTABLE 3 Bending and orientational results
Sample
T-cell mimic
Sxray
HIV mimic
KC KC
Membrane 7.1 0.71 3.5
/WT(40:1) 5.4 0.72 3.5
/WT(20:1) 3.2 0.73 2.3
/MX2(40:1) 2.2 0.67 2.9
/MX2(20:1) 1.7 0.72 3.8
/CracWTpal(40:1) 6.4 0.74 4.2
/CracWTpal(20:1) 5.3 0.78 3.7
/CracWT(40:1) 8.2 0.70 3.2
/CracWT(20:1) 9.6 0.64 3.0
/CracMX2pal(40:1) – – –
/CracMX2pal(20:1) – – 2.4
Membrane mimics and samples are as in Table 2, but also include HIV-neg (HI
branes. KC units are 1020 J.
aThis sample did not reach full hydration.lipids (37). The fact that the KC values in the T-cell
samples were sensitive to these peptides and their concen-
trations is further confirmation that these peptides strongly
bound into the T-cell membrane mimic. When WT was
added, KC decreased considerably, and it decreased even
more when MX2 was added. Adding Crac to WT increased
KC, whereas the further addition of palmitic acid reduced
KC. An interesting result for the HIV membrane mimic
and for the HIV-neg membrane mimic as well as for the
HIV extracted lipid membrane is that their KC values are
quite low (Table 3) compared to many lipid bilayers
(37,38) of the same thickness (39). For this study, the
most important result is that the peptide variants had little
effect on the KC values of the HIV membrane mimic and
of the HIV extracted lipid membrane. This supports the
conclusion from the form factor results that these peptides
do not perturb the HIV membrane mimic.WAXS
Fig. 4 shows WAXS from four membrane mimics. For three
membrane mimics, T-cell, HIV, and HIV-neg, the WAXS is
typical of a liquid-ordered phase with intensity centered on
the equator at qrz 1.5 A˚
1. In contrast, the WAXS data for
HIV-chol in Fig. 4 d reveal two separate wide-angle in-plane
scattering features: the sharp, intense Bragg rod on the equa-
tor at qrz 1.5 A˚
1 due to a nontilted gel phase chain-chain
correlation and the diffuse arc beginning at qr z 1.4 A˚
1
due to a fluid phase chain correlation. Similarly, in the
low-angle region at qzz 0.6 A˚
1 above the dark beamstop,
there are two closely spaced orders indicating two coexist-
ing D-spacings. This gel-fluid phase coexistence prevents
determining the bending modulus and the structure as well
as the Sxray order parameter. This phase coexistence per-
sisted in all of the HIV-chol samples (even with peptides)
at all hydration levels. Interestingly, one role of cholesterol
in the HIV membrane may be to prevent a gel-fluid phase
separation.Sxray
HIV-neg mimic
Sxray
HIV extracted
KC KC
0.80 3.0 0.80 2.6
0.79 3.0 0.78 2.9
0.78 – 0.81 –
0.77 2.9 0.79 a
0.80 2.8 0.77 –
0.77 3.8 0.78 3.7
0.78 2.5 0.79 –
0.77 3.7 0.72 1.9
0.73 3.4 0.72 –
– 2.5 0.79 2.5
0.81 2.6 0.76 –
V mimic without negatively charged lipids) and HIV extracted lipid mem-
Biophysical Journal 105(3) 657–666
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FIGURE 4 WAXS from lipid membranes at 37C, a, T-cell, b, HIV, c,
HIV-neg, and d, HIV-chol. In d, an intense (white) gel phase peak (qr z
1.5 A˚1) and diffuse Ld (fluid) phase scattering (qr z 1.4 A˚
1) indicate
gel-fluid phase coexistence.
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Table 3 also shows the values of the Sxray order parameter
obtained by analyzing WAXS data as shown in Fig. 4 for
the membrane mimics and in Fig. S4 for all the samples.
Sxray is analogous to the NMR SCD order parameter in that
it reports molecular orientational order (14,30). Sxray is
somewhat smaller for the T-cell membrane mimic than for
the HIV and HIV-neg membrane mimics, which is consis-
tent with its lower cholesterol content (30% vs. 45%) (30).
The main point of the Sxray results is that, within uncertainty,
none of the LLP2 variants significantly changed Sxray of the
HIV membrane mimic, consistent with their not entering the
HIV membrane mimic. When the CracWTpal peptide was
added to the T-cell mimic, the membrane order increased,
but it did not increase when just CracWTwas added, demon-
strating the importance of the palmitoyl group, but not the
Crac motif, for increasing membrane order.FIGURE 5 Cartoon showing differences in the interaction of LLP2 with
T-cell and HIV membranes. (a) WT LLP2 binds to the outer headgroup re-
gion and thins the T-cell membrane. (b) MX2 LLP2 binds more deeply into
the hydrocarbon interior and thins the T-cell membrane to a greater extent.
(c) WT and MX2 LLP2 only weakly bind to the HIV virion membrane.CD
CD spectra obtained from hydrated thin films were analyzed
for secondary peptide structure. An example of the Dichro-
WEB fit to the CD spectrum from hydrated HIV membrane
mimic/CracMX2pal (20:1) is shown in Fig. S7 a. The results
of our analysis (Table S1) indicate that the peptides in all
three membrane mimics were primarily a-helical, but with
significant b-strand and random coil. CD spectra for theBiophysical Journal 105(3) 657–66620:1 membrane mimic/peptide samples are shown in
Fig. S7, b–d. Interestingly, the helical content of the LLP2
peptides in solution with no lipid was smaller (Table S2);
this difference between membrane and solution CD further
supports the conclusion drawn from x-ray D-spacing data
that LLP2 associates, albeit weakly, with the HIV mimic.DISCUSSION
Our most important result is that LLP2 interacts strongly
with lipid bilayers that mimic the T-cell membrane and
only weakly with bilayers that mimic the HIV membrane
or with HIV extracted lipid membranes. This result is
most obvious in our LAXS form factor data F(qz) shown
in Fig. 2. It is supported by our results in Table 3 that the
bending modulus decreases with the addition of LLP2 to
the T-cell but not to the HIV membrane mimics or extracted
HIV lipid samples, and it is consistent with our results for
the effect on the order parameter Sxray obtained from wide
angle (WAXS) scattering in Table 3. This dramatic differ-
ence in interaction of all of the LLP2 variants with the
T-cell mimic compared to the HIV mimic with two different
lipid compositions was at first astonishing to us. However,
Dick et al. (40) similarly found that HIV-1 Gag protein
(and the shorter MA segment) strongly preferred lipids
with both acyl chains unsaturated over those with only
one chain unsaturated, and the addition of cholesterol
increased Gag binding and led to closer packing of phospho-
lipids. Nevertheless, it is important to note that LLP2 does
interact, albeit weakly, with the HIV mimic, as indicated
by its effect on the lamellar D-spacing and by its having
greater helical content than in solution. More detailed dis-
cussion regarding this weak binding is elaborated in the
last paragraph in the Supporting Material. The cartoon in
Fig. 5 summarizes the interaction of LLP2 WT and the
mutant MX2 with the two membrane mimics.
Membrane Structure Correlates to LLP2 Function 663This result for the interaction of LLP2 explains, at a bio-
physical level, why there is a clear difference in the biolog-
ical effects of the MX2 R->E mutations in LLP2. Although
the MX2 mutant did not alter Env incorporation or infec-
tivity, which involve the HIV virion membrane, it did
inhibit viral-initiated T-cell death and syncytium formation,
which involve only the T-cell membrane (10). In the latter
case, there are Env proteins located on the surface of an
infected T-cell membrane, but they are not yet localized to
a high-cholesterol domain, such as during budding of the
new HIV virion. Many of these surface Env proteins get
endocytosed before they can be incorporated into virions,
but some of them bind to CD4 receptors on other T-cells,
causing a large, multinucleated cell that eventually dies. It
is remarkable that a peptide in a cytoplasmic location can
affect what happens on the exterior of the membrane. Our
result implies that interaction with a membrane is important
for LLP2 to have a biological effect. This is consistent with
the hypothesis that the membrane transduces information
embedded in the CTT sequence to the major part of the
Env protein that resides on the other side of the membrane.
When there is only a weak interaction with the HIV mem-
brane mimic, the MX2 mutant has no effect. When LLP2
interacts with the T-cell membrane mimic our results
show that the MX2 mutant embeds differently into the
T-cell mimic than the WT. Such a difference is well corre-
lated with the functional inhibition of syncytium formation
by the MX2 mutant.
A theoretical challenge is to understand how the cyto-
plasmic CTT influences the extracellular domain of the
gp41 Env protein. A potential biophysical mechanism
involves the lateral pressure profile of the membrane
(41), which would be affected locally by embedded
LLP2 and which would then affect other nearby parts of
gp41, such as the transmembrane domain (TMD). Pertur-
bation of the TMD of gp41 could affect the conformational
changes necessary for fusion as several studies with modi-
fied TMDs have demonstrated inhibition of fusion (42–44).
With regard to the T-cell membrane, the deeper embedding
of MX2 would alter the lateral pressure profile compared
to WT and that would affect the TMD of the gp41 Env pro-
tein differently, correlating well to the inhibition of cell-
cell fusion upon mutation. It is important to emphasize in
this theory that it is the difference in the lateral pressure
profile between WT and MX2 that modulates biological
function, not that MX2 binds more deeply and therefore
might affect the membrane more than WT. Finally, with
regard to the HIV membrane mimic, the very weak inter-
action of LLP2, either WT or MX2, predicts that MX2
would have little effect on Env incorporation or infectivity,
as observed.
Another potential mechanism might have been the soft-
ening of the T-cell membrane mimic by LLP2, which could
then have led to highly curved fusion intermediates, as we
have hypothesized for the HIV FP23 fusion peptide (39).However, in this work, the bending modulus decreases
more with MX2 than with WT, and it increases above that
of the T-cell mimic when the Crac motif is added; therefore
our data contradict membrane softening as the biophysical
mechanism for LLP2’s effect.
It is of interest to correlate the difference in the interaction
of LLP2 with the lipid compositions of the membrane
mimics. The HIV membrane mimic has less disaturated
chain lipid dihydrosphingomyelin (1.7 compared to
2.7 mol %) and less negatively charged phosphoinositol
(1.3 mol %) compared to the T-cell (6.3 mol %), decreasing
the overall negative charge in the T-cell (0.2e/lipid) to 0.15e/
lipid in the HIV membrane mimic. However, the largest dif-
ference is 45 mol % cholesterol in the HIV membrane
mimic compared to 30 mol % in the T-cell membrane
mimic. With such a high concentration of cholesterol it is
surprising that the HIV membrane mimic has such a low
bending modulus, KC, which indicates more flexibility
than the average single component lipid bilayer. This low
KC does not depend on negative charge, because HIV-neg
had an equally low KC, which is consistent with other
studies that have shown that lipid negative charges have a
negligible effect on KC (46,47). Because the KC of the
HIV membrane mimic is quite low, this softer membrane
more easily forms highly curved intermediates during fusion
with its host cell (48). Previously, Kol et al. (49) found that
the immature HIV virion that had CTT engaged with the
p55Gag was twice as stiff as the mature virion that had the
CTT disengaged from the p55Gag. Our study did not involve
p55Gag, but our result that our HIV membrane mimic and
HIV extracted lipids are quite soft when there are no other
associated proteins is consistent with Kol et al. (49).
Although it may seem counterintuitive that membranes
with high cholesterol concentration can be soft, we have
shown before that the effect of cholesterol depends on the
chain length and saturation of the lipids, not just on the
cholesterol concentration (50,51).
It is also of interest to consider the orientation and confor-
mation of LLP2. Our CD results (Fig. S7 and Table 1) show
~55–70% a-helix for all LLP2 variants in T-cell, HIV,
and HIV-neg membrane mimics. A helical structure was
observed in WT LLP2 from several clades of HIV-1 gp41
in 10 mM sodium dodecyl sulfate (SDS) or 60% triflouroe-
thanol, although helical content was not quantified in that
study (52). The differences in helical content are small, so
secondary structure appears unlikely to be the primary cause
of differences in the effects of WT and MX2 in the T-cell
mimic. All of the peptides are more helical when associated
with membrane mimics than in the aqueous phase (see Table
S1 and Table S2). LLP2 helices have large hydrophobic mo-
ments and would therefore be expected to orient either with
the long axis parallel to the surface of membranes as shown
in Fig. 5, or as transmembrane bundles consisting of more
than one or two peptides. Transmembrane bundles have
had prominent in-plane scattering along the qr directionBiophysical Journal 105(3) 657–666
664 Boscia et al.such as occurs for alamethicin (53) and no such scattering
was observed for any of our LLP2 samples.
Given our result that LLP2 peptides interact only weakly
with the HIV membrane mimic, they would be more likely
to oligomerize in solution along their hydrophobic faces,
consistent with a study by Lee et al. (54) that has implicated
LLP2 in Env multimerization. Other studies have implicated
LLP2 interacting with p55Gag during virion formation
(55–58). Env incorporation into cholesterol-rich raft-like
domains could occur by the interaction of LLP2 with the
MA portion of p55Gag, which binds to rafts as other studies
have shown (59–63), but our data are silent on these
possibilities.
Although natural and experimental variations in Env
gp120 and gp41 ectodomain sequences have been studied
in detail as determinants of Env structure and functional
properties, the current data indicate a need to more rigor-
ously evaluate the role of natural CTT variations as a deter-
minant of Env phenotypes, including antibody neutralization
sensitivity, due to its inside-outside signaling ability (64). In
addition, the defined role of CTT-membrane mimic interac-
tions as a determinant of overall Env conformation may in
part explain the failure of experimental immunizations
with HIV Env proteins engineered with deletions of the
entire CTT to reduce cytotoxicity and increase the levels
of Env protein expression (65). These experimental immuni-
zations with CTT-deleted Env constructs have in general
elicited high levels of antibody to the vaccine protein, but
relatively low levels of antibody reactivity with the native
viral Env protein that fail to neutralize viral infectivity. It
is possible that the CTT truncations substantially alter the
conformation of the vaccine Env protein compared to the
native full length viral Env protein. Thus, these data indicate
the importance of designing HIV vaccines to express full-
length membrane-associated Env protein to maximize the
production of antibody responses that recognize and inacti-
vate the native Env structure on the surface of viral particles
and infected cells.SUPPORTING MATERIAL
Seven figures and two tables are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(13)00751-0.
Research reported in this publication was supported by the National Insti-
tute of General Medical Sciences of the National Institutes of Health under
award number R01GM44976 (PIs J.F.N., S.T.N.) and the National Institute
of Allergy and Infectious Diseases of the National Institutes of Health under
award number R01AI087533(PI RCM). The content is solely the responsi-
bility of the authors and does not necessarily represent the official views of
the National Institutes of Health. A.L.B. was partially supported by the
Howard Hughes Medical Foundation for undergraduate research. We
acknowledge the Cornell High Energy Synchrotron Source (CHESS),
which is supported by the National Science Foundation (NSF) and the
NIH/NIGMS under NSF award DMR-0936384, and we especially thank
Dr. Arthur Woll for facilitating our use of the G1 station. We acknowledge
the Center for Molecular Analysis at Carnegie Mellon University for use ofBiophysical Journal 105(3) 657–666the Jasco 715 and for mass spectrometry analysis and the Protein Synthesis
Core of the University of Pittsburgh for peptide production. We acknowl-
edge Bradley Treece for help with calculations of Sxray.REFERENCES
1. Costin, J. M., J. M. Rausch,., W. C. Wimley. 2007. Viroporin poten-
tial of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41
protein. Virol. J. 4:1–14.
2. Koenig, B. W., J. A. Ferretti, and K. Gawrisch. 1999. Site-specific
deuterium order parameters and membrane-bound behavior of a
peptide fragment from the intracellular domain of HIV-1 gp41.
Biochemistry. 38:6327–6334.
3. Moreno, M. R., M. Giudici, and J. Villalaı´n. 2006. The membrano-
tropic regions of the endo and ecto domains of HIV gp41 envelope
glycoprotein. Biochim. Biophys. Acta. 1758:111–123.
4. Kliger, Y., and Y. Shai. 1997. A leucine zipper-like sequence from the
cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs
lipid bilayers. Biochemistry. 36:5157–5169.
5. Chen, S. S. L., S. F. Lee, and C. T. Wang. 2001. Cellular membrane-
binding ability of the C-terminal cytoplasmic domain of human immu-
nodeficiency virus type 1 envelope transmembrane protein gp41.
J. Virol. 75:9925–9938.
6. Eisenberg, D., and M. Wesson. 1990. The most highly amphiphilic
alpha-helices include two amino acid segments in human immunodefi-
ciency virus glycoprotein 41. Biopolymers. 29:171–177.
7. Murakami, T., and E. O. Freed. 2000. The long cytoplasmic tail of gp41
is required in a cell type-dependent manner for HIV-1 envelope
glycoprotein incorporation into virions. Proc. Natl. Acad. Sci. USA.
97:343–348.
8. Wilk, T., T. Pfeiffer, and V. Bosch. 1992. Retained in vitro infectivity
and cytopathogenicity of HIV-1 despite truncation of the C-terminal
tail of the env gene product. Virology. 189:167–177.
9. Postler, T. S., and R. C. Desrosiers. 2013. The tale of the long tail: the
cytoplasmic domain of HIV-1 gp41. J. Virol. 87:2–15.
10. Kalia, V., S. Sarkar,., R. C. Montelaro. 2003. Rational site-directed
mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains
in the intracytoplasmic tail of human immunodeficiency virus type 1
gp41 indicate common functions in cell-cell fusion but distinct roles
in virion envelope incorporation. J. Virol. 77:3634–3646.
11. Kalia, V., S. Sarkar,., R. C. Montelaro. 2005. Antibody neutralization
escape mediated by point mutations in the intracytoplasmic tail of
human immunodeficiency virus type 1 gp41. J. Virol. 79:2097–2107.
12. Liu, Y. F., and J. F. Nagle. 2004. Diffuse scattering provides material
parameters and electron density profiles of biomembranes. Phys. Rev.
E Stat. Nonlin. Soft Matter Phys. 69:040901–040904 (R).
13. Kucerka, N., Y. F. Liu,., J. F. Nagle. 2005. Structure of fully hydrated
fluid phase DMPC and DLPC lipid bilayers using X-ray scattering from
oriented multilamellar arrays and from unilamellar vesicles. Biophys. J.
88:2626–2637.
14. Mills, T. T., G. E. S. Toombes,., J. F. Nagle. 2008. Order parameters
and areas in fluid-phase oriented lipid membranes using wide angle
X-ray scattering. Biophys. J. 95:669–681.
15. Lyatskaya, Y., Y. F. Liu, ., J. F. Nagle. 2001. Method for obtaining
structure and interactions from oriented lipid bilayers. Phys. Rev. E
Stat. Nonlin. Soft Matter Phys. 63:011907.
16. Bru¨gger, B., B. Glass,., H. G. Kra¨usslich. 2006. The HIV lipidome: a
raft with an unusual composition. Proc. Natl. Acad. Sci. USA.
103:2641–2646.
17. Chan, R., P. D. Uchil, ., M. R. Wenk. 2008. Retroviruses human
immunodeficiency virus and murine leukemia virus are enriched in
phosphoinositides. J. Virol. 82:11228–11238.
18. Greenwood, A. I., J. J. Pan,., S. Tristram-Nagle. 2008. CRAC motif
peptide of the HIV-1 gp41 protein thins SOPCmembranes and interacts
with cholesterol. Biochim. Biophys. Acta. 1778:1120–1130.
Membrane Structure Correlates to LLP2 Function 66519. Li, H., and V. Papadopoulos. 1998. Peripheral-type benzodiazepine
receptor function in cholesterol transport. Identification of a putative
cholesterol recognition/interaction amino acid sequence and consensus
pattern. Endocrinology. 139:4991–4997.
20. Epand, R. M., B. G. Sayer, and R. F. Epand. 2003. Peptide-induced
formation of cholesterol-rich domains. Biochemistry. 42:14677–14689.
21. Rousso, I., M. B. Mixon, ., P. S. Kim. 2000. Palmitoylation of the
HIV-1 envelope glycoprotein is critical for viral infectivity. Proc.
Natl. Acad. Sci. USA. 97:13523–13525.
22. Yang, C. L., C. P. Spies, and R. W. Compans. 1995. The human and
simian immunodeficiency virus envelope glycoprotein transmembrane
subunits are palmitoylated. Proc. Natl. Acad. Sci. USA. 92:9871–9875.
23. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extrac-
tion and purification. Can. J. Biochem. Physiol. 37:911–917.
24. Steckbeck, J. D., C. Q. Sun,., R. C. Montelaro. 2010. Topology of the
C-terminal tail of HIV-1 gp41: differential exposure of the Kennedy
epitope on cell and viral membranes. PLoS ONE. 5:e15261.
25. Tristram-Nagle, S. A. 2007. Preparation of oriented, fully hydrated
lipid samples for structure determination using X-ray scattering.
Methods Mol. Biol. 400:63–75.
26. Raghunathan, M., Y. Zubovski,., S. Tristram-Nagle. 2012. Structure
and elasticity of lipid membranes with genistein and daidzein bio-
flavinoids using X-ray scattering and MD simulations. J. Phys.
Chem. B. 116:3918–3927.
27. Kucerka, N., J. F. Nagle,., J. Katsaras. 2008. Lipid bilayer structure
determined by the simultaneous analysis of neutron and X-ray scat-
tering data. Biophys. J. 95:2356–2367.
28. Nagle, J. F., and M. C. Wiener. 1989. Relations for lipid bilayers.
Connection of electron density profiles to other structural quantities.
Biophys. J. 55:309–313.
29. Kucerka, N., M. A. Kiselev, and P. Balgavy´. 2004. Determination of
bilayer thickness and lipid surface area in unilamellar dimyristoylphos-
phatidylcholine vesicles from small-angle neutron scattering curves: a
comparison of evaluation methods. Eur. Biophys. J. 33:328–334.
30. Mills, T. T., S. Tristram-Nagle, ., G. W. Feigenson. 2008. Liquid-
liquid domains in bilayers detected by wide angle X-ray scattering.
Biophys. J. 95:682–690.
31. Wu, Y., H. W. Huang, and G. A. Olah. 1990. Method of oriented circu-
lar dichroism. Biophys. J. 57:797–806.
32. Merzlyakov, M., E. Li, and K. Hristova. 2006. Directed assembly of
surface-supported bilayers with transmembrane helices. Langmuir.
22:1247–1253.
33. Lobley, A., L. Whitmore, and B. A. Wallace. 2002. DICHROWEB: an
interactive website for the analysis of protein secondary structure from
circular dichroism spectra. Bioinformatics. 18:211–212.
34. Abdul-Gader, A., A. J. Miles, and B. A. Wallace. 2011. A reference
dataset for the analyses of membrane protein secondary structures
and transmembrane residues using circular dichroism spectroscopy.
Bioinformatics. 27:1630–1636.
35. Mutz, M., and W. Helfrich. 1989. Unbinding transition of a biological
model membrane. Phys. Rev. Lett. 62:2881–2884.
36. Helfrich, W., and J. Prost. 1988. Intrinsic bending force in anisotropic
membranes made of chiral molecules. Phys. Rev. A. 38:3065–3068.
37. Kucerka, N., S. Tristram-Nagle, and J. F. Nagle. 2005. Structure of
fully hydrated fluid phase lipid bilayers with monounsaturated chains.
J. Membr. Biol. 208:193–202.
38. Rawicz, W., K. C. Olbrich,., E. Evans. 2000. Effect of chain length
and unsaturation on elasticity of lipid bilayers. Biophys. J. 79:328–339.
39. Tristram-Nagle, S., and J. F. Nagle. 2007. HIV-1 fusion peptide
decreases bending energy and promotes curved fusion intermediates.
Biophys. J. 93:2048–2055.
40. Dick, R. A., S. L. Goh, ., V. M. Vogt. 2012. HIV-1 Gag protein can
sense the cholesterol and acyl chain environment in model membranes.
Proc. Natl. Acad. Sci. USA. 109:18761–18766.41. Cantor, R. S. 1999. Lipid composition and the lateral pressure profile in
bilayers. Biophys. J. 76:2625–2639.
42. Shang, L., L. Yue, and E. Hunter. 2008. Role of the membrane-
spanning domain of human immunodeficiency virus type 1 envelope
glycoprotein in cell-cell fusion and virus infection. J. Virol. 82:5417–
5428.
43. West, J. T., P. B. Johnston, ., E. Hunter. 2001. Mutations within
the putative membrane-spanning domain of the simian immuno-
deficiency virus transmembrane glycoprotein define the minimal
requirements for fusion, incorporation, and infectivity. J. Virol.
75:9601–9612.
44. Kondo, N., K. Miyauchi, ., Z. Matsuda. 2010. Conformational
changes of the HIV-1 envelope protein during membrane fusion are
inhibited by the replacement of its membrane-spanning domain.
J. Biol. Chem. 285:14681–14688.
45. Reference deleted in proof.
46. Song, J., and R. E. Waugh. 1990. Bilayer membrane bending stiffness
by tether formation from mixed PC-PS lipid vesicles. J. Biomech. Eng.
112:235–240.
47. Rowat, A. C., P. L. Hansen, and J. H. Ipsen. 2004. Experimental evi-
dence of the electrostatic contribution to membrane rigidity. Europhys.
Lett. 67:144–149.
48. Siegel, D. P. 2008. The Gaussian curvature elastic energy of intermedi-
ates in membrane fusion. Biophys. J. 95:5200–5215.
49. Kol, N., Y. Shi,., I. Rousso. 2007. A stiffness switch in human immu-
nodeficiency virus. Biophys. J. 92:1777–1783.
50. Pan, J. J., T. T. Mills,., J. F. Nagle. 2008. Cholesterol perturbs lipid
bilayers nonuniversally. Phys. Rev. Lett. 100:198103.
51. Pan, J. J., S. Tristram-Nagle, and J. F. Nagle. 2009. Effect of cholesterol
on structural and mechanical properties of membranes depends on lipid
chain saturation. Phys. Rev. E. 80:021931.
52. Steckbeck, J. D., J. K. Craigo, ., R. C. Montelaro. 2011. Highly
conserved structural properties of the C-terminal tail of HIV-1 gp41
protein despite substantial sequence variation among diverse clades:
implications for functions in viral replication. J. Biol. Chem.
286:27156–27166.
53. Pan, J. J., S. Tristram-Nagle, and J. F. Nagle. 2009. Alamethicin aggre-
gation in lipid membranes. J. Membr. Biol. 231:11–27.
54. Lee, S. F., C. T. Wang,., S. S. L. Chen. 2000. Multimerization poten-
tial of the cytoplasmic domain of the human immunodeficiency virus
type 1 transmembrane glycoprotein gp41. J. Biol. Chem. 275:15809–
15819.
55. Bhatia, A. K., N. Campbell, ., L. Ratner. 2007. Characterization of
replication defects induced by mutations in the basic domain and C-ter-
minus of HIV-1 matrix. Virology. 369:47–54.
56. Freed, E. O., and M. A. Martin. 1996. Domains of the human immuno-
deficiency virus type 1 matrix and gp41 cytoplasmic tail required for
envelope incorporation into virions. J. Virol. 70:341–351.
57. Freed, E. O., J. M. Orenstein, ., M. A. Martin. 1994. Single amino
acid changes in the human immunodeficiency virus type 1 matrix
protein block virus particle production. J. Virol. 68:5311–5320.
58. Hourioux, C., D. Brand, ., P. Roingeard. 2000. Identification of the
glycoprotein 41(TM) cytoplasmic tail domains of human immunodefi-
ciency virus type 1 that interact with Pr55Gag particles. AIDS Res.
Hum. Retroviruses. 16:1141–1147.
59. Ono, A., and E. O. Freed. 2001. Plasma membrane rafts play a critical
role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA.
98:13925–13930.
60. Lindwasser, O. W., and M. D. Resh. 2001. Multimerization of human
immunodeficiency virus type 1 Gag promotes its localization to barges,
raft-like membrane microdomains. J. Virol. 75:7913–7924.
61. Ono, A., A. A. Waheed,., E. O. Freed. 2005. Association of human
immunodeficiency virus type 1 gag with membrane does not require
highly basic sequences in the nucleocapsid: use of a novel Gag multi-
merization assay. J. Virol. 79:14131–14140.Biophysical Journal 105(3) 657–666
666 Boscia et al.62. Patil, A., A. Gautam, and J. Bhattacharya. 2010. Evidence that Gag
facilitates HIV-1 envelope association both in GPI-enriched plasma
membrane and detergent resistant membranes and facilitates envelope
incorporation onto virions in primary CD4þ T cells. Virol. J. 7:1–5.
63. Saad, J. S., J. Miller,., M. F. Summers. 2006. Structural basis for tar-
geting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Proc. Natl. Acad. Sci. USA. 103:11364–11369.Biophysical Journal 105(3) 657–66664. Wyss, S., A. S. Dimitrov,., J. A. Hoxie. 2005. Regulation of human
immunodeficiency virus type 1 envelope glycoprotein fusion by a
membrane-interactive domain in the gp41 cytoplasmic tail. J. Virol.
79:12231–12241.
65. Checkley, M. A., B. G. Luttge, and E. O. Freed. 2011. HIV-1 envelope
glycoprotein biosynthesis, trafficking, and incorporation. J. Mol. Biol.
410:582–608.
